X4 PHARMACEUTICALS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ________, 20__ Debt SecuritiesIndenture • August 7th, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2020 Company Industry JurisdictionINDENTURE, dated as of ________, 20__, among X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
X4 Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 7th, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2020 Company Industry Jurisdiction
X4 PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • August 7th, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2020 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
X4 PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFCommon Stock Warrant Agreement • August 7th, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2020 Company Industry JurisdictionCOMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
X4 PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • August 7th, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2020 Company Industry JurisdictionDEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).